<?xml version="1.0"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
<channel>
<title>BloggingStocks</title>
<link>http://www.bloggingstocks.com</link>
<description>BloggingStocks</description>
<image>
<url>http://www.blogsmithmedia.com/http://www.bloggingstocks.com/media/feedlogo.gif</url>
<title>BloggingStocks</title>
<link>http://www.bloggingstocks.com</link>
</image>
<language>en-us</language>
<copyright>Copyright 2012 Weblogs, Inc. The contents of this feed are available for non-commercial use only.</copyright>
<generator>Blogsmith http://www.blogsmith.com/</generator><item><title><![CDATA[Global pharma favorites]]></title><link>http://www.bloggingstocks.com/2009/05/14/global-pharma-favorites/</link><guid isPermaLink="true">http://www.bloggingstocks.com/2009/05/14/global-pharma-favorites/</guid><comments>http://www.bloggingstocks.com/2009/05/14/global-pharma-favorites/#comments</comments><description><![CDATA[<p>Filed under: <a href="http://www.bloggingstocks.com/category/international-markets/" rel="tag">International Markets</a>, <a href="http://www.bloggingstocks.com/category/newsletters/" rel="tag">Newsletters</a>, <a href="http://www.bloggingstocks.com/category/akam/" rel="tag">Akamai Technologies (AKAM)</a>, <a href="http://www.bloggingstocks.com/category/stocks-to-buy/" rel="tag">Stocks to Buy</a></p><p>In a review of the pharmaceutical sector, <a href="http://www.thestockadvisors.com/ccount/click.php?id=3103 ">Chuck Carlson</a> selects his favorite International stocks which also offer direct-purchase plans for U.S. investors.</p>
<p>Here's a look at two of these stocks -- United Kingdom-based <a href="http://finance.aol.com/quotes/astrazeneca-plc/azn/nys">AstraZeneca</a> (NYSE: <a href="http://finance.aol.com/quotes/astrazeneca-plc/azn/nys">AZN</a>) and Denmark-based <a href="http://finance.aol.com/quotes/novo-nordisk-a-s-denmark/nvo/nys">Novo Nordisk</a> (NYSE: <a href="http://finance.aol.com/quotes/novo-nordisk-a-s-denmark/nvo/nys">NVO</a>) -- from his <a href="http://www.thestockadvisors.com/ccount/click.php?id=3103 ">The DRIP Investor</a>, a newsletter focused on long-term, high quality investments.</p>
<p>"AstraZeneca is a leading pharmaceutical firm. The company boasts a portfolio that includes 11 products that generate more than $1 billion each in annual sales. <br /></p><p><a href="http://www.bloggingstocks.com/2009/05/14/global-pharma-favorites/" rel="bookmark">Continue reading <em>Global pharma favorites</em></a></p><p style="padding:5px;background:#ddd;border:1px solid #ccc;clear:both;"><a href="http://www.bloggingstocks.com/2009/05/14/global-pharma-favorites/">Global pharma favorites</a> originally appeared on <a href="http://www.bloggingstocks.com">BloggingStocks</a> on Thu, 14 May 2009 13:30:00 EST.  Please see our <a href="http://www.weblogsinc.com/feed-terms/">terms for use of feeds</a>.</p><h6 style="clear: both; padding: 8px 0 0 0; height: 2px; font-size: 1px; border: 0; margin: 0; padding: 0;"></h6><a href="http://www.bloggingstocks.com/2009/05/14/global-pharma-favorites/" rel="bookmark" title="Permanent link to this entry">Permalink</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/forward/1545916/" title="Send this entry to a friend via email">Email this</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/2009/05/14/global-pharma-favorites/#comments" title="View reader comments on this entry">Comments</a>]]></description><category>astrazeneca</category><category>azn</category><category>chuck carlson</category><category>ChuckCarlson</category><category>drip investor</category><category>drug stocks</category><category>DrugStocks</category><category>global drug stocks</category><category>GlobalDrugStocks</category><category>novo nordisk</category><category>NovoNordisk</category><category>nvo</category><category>pharma stocks</category><category>pharmaceutical stocks</category><category>PharmaStocks</category><category>thestockadvisors.com</category><dc:creator><![CDATA[Steven Halpern]]></dc:creator><pubDate>Thu, 14 May 2009 13:30:00 EST</pubDate></item></channel></rss>
